Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Mice completely lacking immunoproteasomes show major changes in antigen presentation.

Kincaid EZ, Che JW, York I, Escobar H, Reyes-Vargas E, Delgado JC, Welsh RM, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rock KL.

Nat Immunol. 2011 Dec 25;13(2):129-35. doi: 10.1038/ni.2203.

2.

Proteasome isoforms exhibit only quantitative differences in cleavage and epitope generation.

Mishto M, Liepe J, Textoris-Taube K, Keller C, Henklein P, Weberruß M, Dahlmann B, Enenkel C, Voigt A, Kuckelkorn U, Stumpf MP, Kloetzel PM.

Eur J Immunol. 2014 Dec;44(12):3508-21. doi: 10.1002/eji.201444902. Epub 2014 Nov 20.

3.

Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.

Svensson M, Pfeifer J, Stockinger B, Wick MJ.

Behring Inst Mitt. 1997 Feb;(98):197-211. Review.

PMID:
9382741
4.

Immunoproteasomes: structure, function, and antigen presentation.

Ferrington DA, Gregerson DS.

Prog Mol Biol Transl Sci. 2012;109:75-112. doi: 10.1016/B978-0-12-397863-9.00003-1. Review.

5.

Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.

Dörfel D, Appel S, Grünebach F, Weck MM, Müller MR, Heine A, Brossart P.

Blood. 2005 Apr 15;105(8):3199-205. Epub 2004 Dec 23.

7.

Alternative pathways for MHC class I presentation: a new function for autophagy.

Chemali M, Radtke K, Desjardins M, English L.

Cell Mol Life Sci. 2011 May;68(9):1533-41. doi: 10.1007/s00018-011-0660-3. Epub 2011 Mar 10. Review.

PMID:
21390546
8.

Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Neefjes J, Jongsma ML, Paul P, Bakke O.

Nat Rev Immunol. 2011 Nov 11;11(12):823-36. doi: 10.1038/nri3084. Review.

PMID:
22076556
9.

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.

Schnurr M, Chen Q, Shin A, Chen W, Toy T, Jenderek C, Green S, Miloradovic L, Drane D, Davis ID, Villadangos J, Shortman K, Maraskovsky E, Cebon J.

Blood. 2005 Mar 15;105(6):2465-72. Epub 2004 Nov 16.

10.

PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo.

de Graaf N, van Helden MJ, Textoris-Taube K, Chiba T, Topham DJ, Kloetzel PM, Zaiss DM, Sijts AJ.

Eur J Immunol. 2011 Apr;41(4):926-35. doi: 10.1002/eji.201041040. Epub 2011 Mar 1.

11.

Standard and immunoproteasomes show similar peptide degradation specificities.

Zanker D, Chen W.

Eur J Immunol. 2014 Dec;44(12):3500-3. doi: 10.1002/eji.201445272. Review.

12.

Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.

Bosch B, Berger AC, Khandelwal S, Heipertz EL, Scharf B, Santambrogio L, Roche PA.

J Biol Chem. 2013 Aug 23;288(34):24286-92. doi: 10.1074/jbc.M113.461996. Epub 2013 Jul 11.

14.

Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.

Maehr R, Hang HC, Mintern JD, Kim YM, Cuvillier A, Nishimura M, Yamada K, Shirahama-Noda K, Hara-Nishimura I, Ploegh HL.

J Immunol. 2005 Jun 1;174(11):7066-74.

15.

Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.

Steers NJ, Peachman KK, McClain SR, Alving CR, Rao M.

J Virol. 2009 Jul;83(14):7049-61. doi: 10.1128/JVI.00327-09. Epub 2009 Apr 29.

16.

Role of immunoproteasomes in cross-presentation.

Palmowski MJ, Gileadi U, Salio M, Gallimore A, Millrain M, James E, Addey C, Scott D, Dyson J, Simpson E, Cerundolo V.

J Immunol. 2006 Jul 15;177(2):983-90.

17.

Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.

Strehl B, Seifert U, Krüger E, Heink S, Kuckelkorn U, Kloetzel PM.

Immunol Rev. 2005 Oct;207:19-30. Review.

PMID:
16181324
18.

Puromycin-sensitive aminopeptidase limits MHC class I presentation in dendritic cells but does not affect CD8 T cell responses during viral infections.

Towne CF, York IA, Neijssen J, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Neefjes JJ, Rock KL.

J Immunol. 2008 Feb 1;180(3):1704-12.

19.

Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells.

Moffat JM, Cheong WS, Villadangos JA, Mintern JD, Netter HJ.

Vaccine. 2013 Apr 26;31(18):2310-6. doi: 10.1016/j.vaccine.2013.02.042. Epub 2013 Mar 7.

PMID:
23473776

Supplemental Content

Support Center